---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-24-000060"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T04:02:05.289070+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Haemonetics announces Q2 FY2025 results; specific figures unavailable from provided filing text

## Summary
- Company issued press release for quarter ended Sept 28, 2024 and first half of fiscal 2025.
- No revenue, EPS, or segment data are included in the 8-K filing text provided.
- Investors should consult the full press release for detailed financial results.
- CEO Christopher A. Simon signed the Form 8-K on November 7, 2024.

## SEC filing metadata
- accession: 0000313143-24-000060
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/0000313143-24-000060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314324000060/hae-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-24-000060
- JSON: https://secwatch.observer/filing/0000313143-24-000060.json
- Plain text: https://secwatch.observer/filing/0000313143-24-000060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.